Martin Shkreli Is At It Again, Refuses To Lower Price Of $750 Drug
The Turing Pharmaceuticals CEO promised to lower the drug price after hiking it up when his company acquired it. But it seems that isn't happening.By Melissa Prax | November 26, 2015
Remember Martin Shkreli, arguably the most hated man in pharmaceuticals for raising the cost of a drug HIV patients regularly take by 5,000 percent? Well, he's getting some very unwanted attention again.
Patients, the medical community and the media blasted Shkreli for the move, and eventually he did say he'd reverse the price increase.